Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity-Reference-Cited by-同舟云学术

Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity

Published:2023-11 Issue:6 Volume:10 Page:
ISSN:2332-7812
Container-title:Neurology Neuroimmunology & Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Bose Gauruv¹^ORCID,Healy Brian C.¹,Saxena Shrishti¹,Saleh Fermisk¹,Glanz Bonnie I.¹,Bakshi Rohit¹^ORCID,Weiner Howard L.¹,Chitnis Tanuja¹

Affiliation:

1. From the Department of Neurology (G.B., B.C.H., S.S., F.S., B.I.G., R.B., H.L.W., T.C.), Brigham and Women's Hospital, Boston, MA; Harvard Medical School (G.B., B.C.H., B.I.G., R.B., H.L.W., T.C.), Boston, MA; The University of Ottawa and Ottawa Hospital Research Institute (G.B.), Ottawa, Canada.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Neurology

Link

https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000200167

Reference43 articles.

2. Economic burden of multiple sclerosis and the role of managed sare organizations in multiple sclerosis management;Owens GM;Am J Manag Care,2016

3. Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network

4. Precision medicine in the multiple sclerosis clinic: Selecting the right patient for the right treatment

5. Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MS treatment de-escalation: review and commentary;Journal of Neurology;2024-08-02

2. De-escalation and Discontinuation of Disease-Modifying Therapies in Multiple Sclerosis;Current Neurology and Neuroscience Reports;2024-07-12